CIRCULAR miRNA SPONGES
AssigneeNational University of Singapore
InventorsAnnadoray Lavenniah, Roger Foo, Matthew Ackers-Johnson
Life of this patent
Estimating the term…
Loading patent…
AssigneeNational University of Singapore
InventorsAnnadoray Lavenniah, Roger Foo, Matthew Ackers-Johnson
Estimating the term…
The present invention relates to miRNA interference technology. More specifically the invention relates to circular miRNA sponges that carry a plurality of binding sites directed to at least two types of miRNA and separated by random, non-identical spacers, allowing for the inhibition of functional classes of m1RNAs. Preferably, the binding sites are bulged binding sites wherein each bulge is created by a one base deletion and two base mismatch at positions 9-11 nt from the 3′ end of each binding site. Preferably, each spacer is 6 to 24 nucleotides in length. Preferably, the binding sites are against miR-132 and miR-212, miR-17-5p and miR-18a-5p, or miR-20b-5p and miR-106a-5p. Construction vectors and uses of said miRNA sponges for the treatment of diseases, such as cardiomyopathy and cancer, are also disclosed.
An isolated circular RNA polynucleotide microRNA sponge, comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of optimizing the structure of a circular RNA polynucleotide microRNA sponge comprising a plurality of bulged binding sites directed to human or non-human animal target miRNA, comprising the steps;
Dependencies are inferred from the claim text.